臨床研究等提出・公開システム

Multicenter study evaluating Feasibility & Usefulness of TEG6s PlateletMapping dUring Flow diverteR stEnting (FUTURE study)

FUTURE study (FUTURE study)

Imamura Hirotoshi

National Cerebral and Cardiovascular Center Hospital

6-1 Kishibe-Shimmachi, Suita, Osaka

i-hiro@zg7.so-net.ne.jp

Imamura Hirotoshi

National Cerebral and Cardiovascular Center Hospital

6-1 Kishibe-Shimmachi, Suita, Osaka

+81-6-6170-1070

i-hiro@zg7.so-net.ne.jp

Complete

Jan. 07, 2022

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

other

1) Over 20 years old and more at the time of consent acquisition
2) Patients planning to undergo Flow diverter placement for unruptured cerebral aneurysm
3) Patients who have been taking or are scheduled to take aspirin and clopidogrel for more than 5 days before procedure
4) Patients with written consent

1) Patients planning to change the content of antiplatelet drugs on the day of procedure
2) Patients on warfarin or direct oral anticoagulant (DOAC)
3) Patients contraindicated for MRI examination

Both

Unruptured cerebral aneurysm

Blood test

Cut-off values for ADP-MA and ADP-inhibition% for the incidence rate of symptomatic stroke

Symptomatic ischemic stroke, high signal on diffusion-weighted images, hemorrhagic stroke

+81-78-302-5176

No

none